Regulus Therapeutics Inc. (RGLS)
NASDAQ: RGLS · Real-Time Price · USD
1.610
+0.050 (3.21%)
Jan 3, 2025, 4:00 PM EST - Market closed
Regulus Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jan '25 Jan 3, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 105 | 26 | 23 | 46 | 90 | 19 | |
| Market Cap Growth | 285.04% | 12.20% | -49.82% | -49.09% | 384.92% | 128.72% | |
| Enterprise Value | 19 | -1 | -15 | 19 | 87 | 20 | |
| Last Close Price | 1.61 | 1.28 | 1.37 | 3.15 | 13.50 | 8.90 | |
| PS Ratio | - | - | - | - | 9.03 | 2.73 | |
| PB Ratio | 1.21 | 1.22 | 0.69 | 0.84 | 3.47 | 0.93 | |
| P/TBV Ratio | 1.18 | 1.22 | 0.69 | 0.84 | 3.49 | 0.94 | |
| EV/Sales Ratio | - | - | - | - | 8.67 | 2.90 | |
| Debt / Equity Ratio | 0.01 | 0.15 | 0.21 | 0.14 | 0.20 | 0.79 | |
| Asset Turnover | - | - | - | - | 0.25 | 0.20 | |
| Inventory Turnover | 7.25 | 7.03 | 6.12 | 5.63 | 4.24 | - | |
| Quick Ratio | 13.47 | 2.79 | 3.36 | 11.55 | 2.73 | 1.63 | |
| Current Ratio | 14.14 | 3.31 | 3.78 | 12.48 | 3.17 | 1.87 | |
| Return on Equity (ROE) | -72.36% | -110.27% | -64.19% | -68.68% | -68.33% | -262.58% | |
| Return on Assets (ROA) | -42.39% | -50.20% | -30.65% | -32.78% | -22.20% | -30.06% | |
| Return on Capital (ROIC) | -46.31% | -60.28% | -34.32% | -37.07% | -26.44% | -45.27% | |
| Earnings Yield | -39.47% | -116.04% | -122.76% | -60.48% | -17.42% | -99.82% | |
| FCF Yield | -34.48% | -105.78% | -112.21% | -53.02% | -13.88% | -107.61% | |
| Buyback Yield / Dilution | -148.48% | -24.25% | -78.07% | -145.01% | -102.65% | -97.97% | |
| Total Shareholder Return | -148.48% | -24.25% | -78.07% | -145.01% | -102.65% | -97.97% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.